The present invention relates to electrocoagulation treatment of aqueous liquids.
Electrocoagulation is a water treatment technique in which an aqueous liquid to be treated is passed between two electrically powered electrodes, an anode and a cathode, connected to an electrical power source that causes an electrical potential to be applied between the electrodes and electrical current to flow between the electrodes and through the liquid. Contaminants to be removed from the liquid form insoluble solids in a flocculated or coagulated form that tend to be relatively easy to separate from the liquid, such as by filtration or sedimentation. During the process, ions of anode material are released from the anode and reactions at the cathode tend to passivate the cathode and reduce its activity over time. Typically, polarity is periodically reversed so that electrodes spend equal time as anode and cathode to provide even wear on electrodes. Due to the loss of material at the anode and the loss of electrode activity at the cathode, the electrodes must occasionally be replaced, and are therefore sometimes referred to as “sacrificial” electrodes. Although electrocoagulation can be conducted using AC (alternating current) electrical power, more commonly it is conducted using DC (direct current) electrical power.
Although a simple configuration for an electrocoagulation reactor includes just two electrodes with a space between the electrodes for flow of the liquid to be treated, the need to treat larger volumes of water and practical design considerations has led to common reactor designs that include banks of large numbers of closely-spaced electrode plates. Such reactors may contain hundreds of electrode plates. The inclusion of a large number of electrode plates, however, introduces significant complexities. For example, reactors that have such a large number of plates also have significant mechanical systems for retaining the large number of plates, and must have a design that accommodates removal and replacement of a large number of plates, as plates are depleted and need to be replaced.
Additional complexities may also be introduced due to the large number of electrical connections that may be required by the use of a large number of electrode plates. For example, one type of reactor design includes large numbers of electrode pairs electrically connected in parallel. The complexity involved with providing electrical power connections to each of the many electrode plates is significant. One design that at least partially addresses this problem reduces the number of powered electrodes (i.e., those with an electrical connection to the electrical power source) by inserting a number of intermediate plates, which do not have such electrical connections, between a pair of powered electrode plates that do have electrical connections. These intermediate plates are in the electrical circuit completed by the aqueous liquid that is being treated in the reactor, and provide a source of metal ions for participation in electrocoagulation reactions. Reactors of this design reduce the number of electrical connections that need to be made, but may have an additional problem relating to the larger separation distance between powered electrode plates that results from inserting the intermediate plates. These reactors have higher resistance and tend to operate at significantly higher voltages at least in some situations than reactor designs in which all plates are powered through electrical connections to the electrical power source. Commercially available input electrical power is often delivered as AC power. For an electrocoagulation reactor requiring DC power, it is necessary to convert the AC power to DC power in a rectifier to provide a DC power source for operation of the electrocoagulation reactor. However, providing the higher DC voltages that may be used in these reactor designs results in more watts of AC power usage.
It would be desirable to have an electrocoagulation reactor with a less complex design and/or that permits efficient use of available AC electrical power.
In one aspect the present invention provides electrocoagulation reactors in which the electrocoagulation occurs within a spirally wound assembly of spaced electrode sheets. In another aspect, the invention provides systems for water purification that include one or more of the electrocoagulation reactors. In one variation, a water purification system includes, downstream of an electrocoagulation reactor, a solids separator for separating solids from the liquid treated in the reactor by electrocoagulation. In yet another aspect, the invention provides methods for treating aqueous liquids, including electrocoagulation treatment in one or more of the electrocoagulation reactors
The spirally wound assembly used in the electrocoagulation reactors of the invention can advantageously be configured generally in a cylindrical shape that can easily be inserted into and retained within a tubular section of a reactor housing. Because of the spirally wound packing of the electrode sheets, a large electrode surface area is obtainable using only two powered electrodes, although use of a greater number of powered electrodes is possible if desired for a particular application. Also, because the separation distance between the powered electrode sheets can be kept small without the need to make a lot of electrical connections, the reactor can be readily designed for operation at lower voltages for many applications. The electrocoagulation reactor, and the spirally wound assembly, may be operated using AC or DC electrical power, but more often is operated using DC electrical power, and often in a range of 1.5 DC volts to 48 volts DC.
Advantageously, in a preferred design the spirally wound assembly can be configured to fit into and efficiently use the space available in a tubular section of a reactor housing. This is possible because spiral winding is well adapted to making a spirally wound assembly that is generally of cylindrical shape, which can be closely fitted into a tubular housing section to efficiently use available internal reactor volume. Also, because all of the electrode surface area needed for the electrocoagulation reaction is contained within the spirally wound structure, the manufacture and maintenance of the electrocoagulation reactor is not particularly complex. Also, changing electrodes as they are depleted can be accomplished relatively easily by opening the reactor housing, removing the old spirally wound assembly, inserting the new spirally wound assembly, replacing any retaining or sealing pieces as needed, and closing the reactor housing. Also, with a tubular design, the electrocoagulation reactor can often be constructed of generally available components, and without significant mechanical complexity. Additionally, such tubular-based reactors are easily manifolded into a bank of multiple reactors for parallel or series processing through the multiple reactors. For example, additional reactors can easily be added in parallel to increase throughput capacity, or additional reactors can easily be added in series to provide for added reactor length, such as for longer reaction times. Because of the modular design, systems can be accurately scaled up from bench scale to application scale. Usually electrocoagulation systems are piloted on a specific water to determine the efficacy of the process and predict the cost. Multiple modules perform the same as opposed to single reactors with different size and numbers of plates than pilot. Also use of a single set of electrodes aids in accurate scaling. Amps per unit area of electrode surface remains consistent on a given water supply.
Reference is now made to the accompanying drawings, to assist in illustrating the various aspects and features of the present invention. In this regard, the following descriptions of particular embodiments for an electrocoagulation reactor, the spirally wound assembly thereof, and systems, methods and uses including an electrocoagulation reactor, are presented herein for purposes of illustration and description. Furthermore, the description is not intended to limit the invention to the particular form or forms disclosed herein. Consequently, variations and modifications commensurate with the teachings presented herein, and the skill and knowledge of the relevant art, are within the scope of the present invention. The embodiments described herein are further intended to explain the best modes known of practicing the invention and to enable others skilled in the art to utilize the invention in such, or other embodiments and with various modifications required by the particular application(s) or use(s) of the present invention.
Disposed within the tubular section 104 of the housing 102 is the spirally wound assembly 120, shown in
The electrode sheets 122 and 124 may be sufficiently rigid that there is no need to place a spacer in the space 132 to maintain the separation between the electrode sheets. This may be the case, for example, when the electrode sheets are sheets made of a sheet metal, such as sheet metal of steel.
In one variation, a spacer is disposed in the space 132 to assist in maintaining a desired separation between the electrode sheets 122 and 124. This is especially preferred in the case when, due to the particular construction of one of both of the electrode sheets 122 and 124, one or both of the electrode sheets 122 and 124 is sufficiently flexible that it is more susceptible to movement within the spirally wound assembly 120. When used, such a spacer should be made of electrically non-conductive material and should be of a construction that does not prevent a desired level of fluid flow through the space 132 between the electrode sheets 122 and 124 during use of the reactor 120. In one variation, the spacer is a permeably porous sheet of electrically non-conductive material, which is preferably also flexible. Such a sheet may be, for example, made of a plastic material. By permeably porous, it is meant that a sheet has openings extending across the thickness of the sheet through which fluid can flow through the sheet from one side of the sheet to the other side of the sheet.
Referring now to
The spirally wound assembly used with the electrocoagulation reactor of the present invention, including the embodiments disclosed in
The spirally wound assembly is versatile, and can be made in a variety of sizes and configurations and with a variety of materials of construction as desired for a particular application. The spirally wound assembly may include any convenient number of windings. Although there are often at least 3 windings, the number of windings could be 20 or more, 50 or more, or even 100 or more. The separation distance between electrode sheets in the spirally wound assembly may be set at any desired distance, although often the separation distance will be at least 0.5 mm, and even more often will be in a range of from 0.5 mm to 25 mm. The spirally wound assembly can also be made to any convenient dimensions. For many situations the length of the spirally wound assembly (measured end-to-end in the longitudinal direction) will be in a range of from 0.1 m to 3 m in length. The diameter of the spirally wound assembly (determined as the diameter of the smallest circle in which will fit the maximum cross-section taken perpendicular to the longitudinal direction) will often be within a range of from 4 cm to 74 cm. When the spirally wound assembly is disposed in a tubular section of a housing, the inside diameter of the tubular section housing will often be in a range of from 5 cm to 75 cm. The spirally wound assembly will often be generally of cylindrical shape, and so it can advantageously be disposed in a tubular housing section to efficiently use internal reactor volume. When the spirally wound assembly is disposed in a tubular housing section, the spirally wound assembly will often have a diameter that is no more than 10 mm smaller than the inside diameter of the tubular section. Also, the spirally wound assembly will often have a large cross-sectional area for flow of liquid to be treated by electrocoagulation. Often, the area available for flow between the electrode sheets of the spirally wound assembly at any cross-section through the spirally wound electrode assembly taken perpendicular to the longitudinal direction of the assembly will be greater than 25%, and may even be as large as 75% or more, of the total area of the cross-section.
The materials of the electrode sheets of the spirally wound assembly are made of an electrically conductive material or materials suitable for providing ions for electrocoagulation. Some preferred metals that may be used include iron, aluminum and titanium, and in one preferred variation the electrode sheets are metallic and contain as a predominant metal component one of these metals. The electrically conductive sheets can also be made from alloys of these or other suitable metals. Steel and stainless steel compositions are some preferred iron-containing metallic materials for the electrode sheets. The different electrode sheets of a spirally wound assembly do not need to be made of the same material.
The embodiments described with reference to
Referring to
During operation of the system, aqueous liquid feed from the feed conduit 220 is fed to one, two or all three of the reactors 210, 212 and 214 depending upon the volume and quality of the liquid to be treated. The reactors are powered by connection to an electrical power source, more typically a DC electrical power source, and the aqueous liquid is treated by electrocoagulation in the reactors 210, 212 and 214. Discharge of treated liquid exiting the reactors 210, 212 and 214 is transferred to the separation vessel 222 through the reactor discharge conduit 224. In the separation vessel, solids settle due to gravity to the bottom of the settling vessel 222, from which a concentrate, or sludge, containing the solids is removed through solids discharge conduit 226. Purified liquid is removed from the separation vessel 222 through the purified liquid discharge conduit 228.
This application claims priority to U.S. Provisional Patent Application 60/948293 filed Jul. 6, 2007, the entire contents of each and every portion of which is incorporated herein by reference as if set forth herein in full. This application is a continuation of prior international patent application PCT/US08/69285, which designated the United States, filed Jul. 6, 2008, the entire contents of each and every portion of which is incorporated herein by reference as is set forth herein in full.
Number | Date | Country | |
---|---|---|---|
60948293 | Jul 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2008/069285 | Jul 2008 | US |
Child | 12168753 | US |